Twin Lakes Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Twin Lakes Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$294K	Hold	1,554	–	–	0.13%	75
2025 Q4	$264K	Sell	1,554 -61	-4%	-$9.35K	0.12%	78
2025 Q3	$213K	Hold	1,615	–	–	0.1%	83
2025 Q2	$171K	Hold	1,615	–	–	0.1%	85
2025 Q1	$201K	Sell	1,615 -300	-16%	-$39.1K	0.14%	83
2024 Q4	$236K	Sell	1,915 -256	-12%	-$30.2K	0.15%	77
2024 Q3	$242K	Hold	2,171	–	–	0.16%	76
2024 Q2	$232K	Hold	2,171	–	–	0.16%	77
2024 Q1	$261K	Hold	2,171	–	–	0.18%	73
2023 Q4	$267K	Sell	2,171 -1,000	-32%	-$125K	0.18%	70
2023 Q3	$410K	Hold	3,171	–	–	0.3%	53
2023 Q2	$393K	Hold	3,171	–	–	0.28%	58
2023 Q1	$464K	Hold	3,171	–	–	0.35%	54
2022 Q4	$505K	Sell	3,171 -61	-2%	-$8.94K	0.39%	49
2022 Q3	$431K	Buy	+3,232	New	+$491K	0.35%	59
2022 Q2	–	Sell	-3,337	Closed	-$519K	–	217
2022 Q1	$519K	Hold	3,337	–	–	0.29%	60
2021 Q4	$425K	Hold	3,337	–	–	0.23%	67
2021 Q3	$435K	Hold	3,337	–	–	0.26%	61
2021 Q2	$593K	Hold	3,337	–	–	0.33%	49
2021 Q1	$549K	Hold	3,337	–	–	0.34%	54
2020 Q4	$551K	Buy	+3,337	New	+$497K	0.39%	51

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Twin Lakes Capital Management's JAZZ Position: Q1 2026 in Review

Twin Lakes Capital Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 1,554 shares worth $294K. The position accounts for 0.13% of the portfolio, ranked #75.

Twin Lakes Capital Management first reported a position in JAZZ in Q4 2020 and has held it in 21 quarters since. The position peaked at $593K in Q2 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Twin Lakes Capital Management held 1,554 shares of Jazz Pharmaceuticals worth $294K as of Q1 2026.
Twin Lakes Capital Management left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
Jazz Pharmaceuticals made up 0.13% of Twin Lakes Capital Management's portfolio in Q1 2026, its #75 holding.
Twin Lakes Capital Management first reported a position in Jazz Pharmaceuticals in Q4 2020 and has held it in 21 quarters since.
Twin Lakes Capital Management's Jazz Pharmaceuticals position peaked at $593K in Q2 2021.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Twin Lakes Capital Management's 13F filing for Q1 2026, filed 18 May 2026.